TY - JOUR AU - Elgueta, R. AU - Benson, M. J. AU - Vries, V. C. AU - Wasiuk, A. AU - Guo, Y. AU - Noelle, R. J. PY - 2009 DA - 2009// TI - Molecular mechanism and function of CD40/CD40L engagement in the immune system JO - Immunol Rev VL - 229 UR - https://doi.org/10.1111/j.1600-065X.2009.00782.x DO - 10.1111/j.1600-065X.2009.00782.x ID - Elgueta2009 ER - TY - JOUR AU - Burkly, L. C. PY - 2001 DA - 2001// TI - CD40 pathway blockade as an approach to immunotherapy JO - Adv Exp Med Biol VL - 489 UR - https://doi.org/10.1007/978-1-4615-1277-6_12 DO - 10.1007/978-1-4615-1277-6_12 ID - Burkly2001 ER - TY - JOUR AU - Kooten, C. AU - Banchereau, J. PY - 2000 DA - 2000// TI - CD40-CD40 ligand JO - J Leukoc Biol VL - 67 ID - Kooten2000 ER - TY - JOUR AU - Gerritse, K. AU - Laman, J. D. AU - Noelle, R. J. AU - Aruffo, A. AU - Ledbetter, J. A. AU - Boersma, W. J. PY - 1996 DA - 1996// TI - CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis JO - Proc Natl Acad Sci U S A VL - 93 UR - https://doi.org/10.1073/pnas.93.6.2499 DO - 10.1073/pnas.93.6.2499 ID - Gerritse1996 ER - TY - JOUR AU - Gobburu, J. V. AU - Tenhoor, C. AU - Rogge, M. C. AU - Frazier, D. E. AU - Thomas, D. AU - Benjamin, C. PY - 1998 DA - 1998// TI - Pharmacokinetics/dynamics of 5c8, a monoclonal antibody to CD154 (CD40 ligand) suppression of an immune response in monkeys JO - J Pharmacol Exp Ther VL - 286 ID - Gobburu1998 ER - TY - JOUR AU - Xu, H. AU - Tadaki, D. K. AU - Elster, E. A. AU - Burkly, L. C. AU - Berning, J. D. AU - Cruzata, F. PY - 2002 DA - 2002// TI - Humanized anti-CD154 antibody therapy for the treatment of allograft rejection in nonhuman primates JO - Transplantation VL - 74 UR - https://doi.org/10.1097/00007890-200210150-00007 DO - 10.1097/00007890-200210150-00007 ID - Xu2002 ER - TY - JOUR AU - Davidson, A. AU - Wang, X. AU - Mihara, M. AU - Ramanujam, M. AU - Huang, W. AU - Schiffer, L. PY - 2003 DA - 2003// TI - Co-stimulatory blockade in the treatment of murine systemic lupus erythematosus (SLE) JO - Ann NY Acad Sci VL - 987 UR - https://doi.org/10.1111/j.1749-6632.2003.tb06048.x DO - 10.1111/j.1749-6632.2003.tb06048.x ID - Davidson2003 ER - TY - JOUR AU - Toubi, E. AU - Shoenfeld, Y. PY - 2004 DA - 2004// TI - The role of CD40-CD154 interactions in autoimmunity and the benefit of disrupting this pathway JO - Autoimmunity VL - 37 UR - https://doi.org/10.1080/08916930400002386 DO - 10.1080/08916930400002386 ID - Toubi2004 ER - TY - JOUR AU - Henn, V. AU - Slupsky, J. R. AU - Gräfe, M. AU - Anagnostopoulos, I. AU - Förster, R. AU - Müller-Berghaus, G. PY - 1998 DA - 1998// TI - CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells JO - Nature VL - 391 UR - https://doi.org/10.1038/35393 DO - 10.1038/35393 ID - Henn1998 ER - TY - JOUR AU - André, P. AU - Nannizzi-Alaimo, L. AU - Prasad, S. K. AU - Phillips, D. R. PY - 2002 DA - 2002// TI - Platelet-derived CD40L: the switch-hitting player of cardiovascular disease JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000028962.04520.01 DO - 10.1161/01.CIR.0000028962.04520.01 ID - André2002 ER - TY - JOUR AU - André, P. AU - Prasad, K. S. S. AU - Denis, C. V. AU - He, M. AU - Papalia, J. M. AU - Hynes, R. O. PY - 2002 DA - 2002// TI - CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism JO - Nat Med VL - 8 UR - https://doi.org/10.1038/nm0302-247 DO - 10.1038/nm0302-247 ID - André2002 ER - TY - JOUR AU - Langer, F. AU - Ingersoll, S. B. AU - Amirkhosravi, A. AU - Meyer, T. AU - Siddiqui, F. A. AU - Ahmad, S. PY - 2005 DA - 2005// TI - The role of CD40 in CD40-L and antibody-mediated platelet activation JO - Thromb Haemost VL - 93 ID - Langer2005 ER - TY - JOUR AU - Elzey, B. D. AU - Ratliff, T. L. AU - Sowa, J. M. AU - Crist, S. A. PY - 2011 DA - 2011// TI - Platelet CD40L at the interface of adaptive immunity JO - Thromb Res VL - 127 UR - https://doi.org/10.1016/j.thromres.2010.10.011 DO - 10.1016/j.thromres.2010.10.011 ID - Elzey2011 ER - TY - JOUR AU - Semple, J. W. AU - Freedman, J. PY - 2010 DA - 2010// TI - Platelets and innate immunity JO - Cell Mol Life Sci VL - 67 UR - https://doi.org/10.1007/s00018-009-0205-1 DO - 10.1007/s00018-009-0205-1 ID - Semple2010 ER - TY - JOUR AU - Boumpas, D. T. AU - Furie, R. AU - Manzi, S. AU - Illei, G. G. AU - Wallace, D. J. AU - Balow, J. E. PY - 2003 DA - 2003// TI - A short course of BG9588 (anti-CD40 ligand antibody) improves serologic activity and decreases hematuria in patients with proliferative lupus glomerulonephritis JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.10856 DO - 10.1002/art.10856 ID - Boumpas2003 ER - TY - JOUR AU - Grammer, A. C. AU - Slota, R. AU - Fischer, R. AU - Gur, H. AU - Girschick, H. AU - Yarboro, C. PY - 2003 DA - 2003// TI - Abnormal germinal center reactions in systemic lupus erythematosus demonstrated by blockade of CD154-CD40 interactions JO - J Clin Invest VL - 112 UR - https://doi.org/10.1172/JCI200319301 DO - 10.1172/JCI200319301 ID - Grammer2003 ER - TY - JOUR AU - Huang, W. AU - Sinha, J. AU - Newman, J. AU - Reddy, B. AU - Budhai, L. AU - Furie, R. PY - 2002 DA - 2002// TI - The effect of anti-CD40 ligand antibody on B cells in human systemic lupus erythematosus JO - Arthritis Rheum VL - 46 UR - https://doi.org/10.1002/art.10273 DO - 10.1002/art.10273 ID - Huang2002 ER - TY - JOUR AU - Kawai, T. AU - Andrews, D. AU - Colvin, R. B. AU - Sachs, D. H. AU - Cosimi, A. B. PY - 2000 DA - 2000// TI - Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand JO - Nat Med VL - 6 UR - https://doi.org/10.1038/72162 DO - 10.1038/72162 ID - Kawai2000 ER - TY - JOUR AU - Wakefield, I. D. AU - Harari, O. AU - Hutto, D. AU - Burkly, L. AU - Ferrant, J. AU - Taylor, F. PY - 2010 DA - 2010// TI - An assessment of the thromboembolic potential of CDP7657, a monovalent Fab' PEG anti-CD40L antibody, in rhesus macaques JO - Arthritis Rheum VL - 62 ID - Wakefield2010 ER - TY - STD TI - Hsu Y-M, Su L. Platelet aggregation assays using a CD40L-binding agent. US patent No. 8409810 B2 (Issued Apr 2, 2013). ID - ref20 ER - TY - JOUR AU - Robles-Carrillo, L. AU - Meyer, T. AU - Hatfield, M. AU - Desai, H. AU - Dávila, M. AU - Langer, F. PY - 2010 DA - 2010// TI - Anti-CD40L immune complexes potently activate platelets in vitro and cause thrombosis in FCGR2A transgenic mice JO - J Immunol VL - 185 UR - https://doi.org/10.4049/jimmunol.0903888 DO - 10.4049/jimmunol.0903888 ID - Robles-Carrillo2010 ER - TY - JOUR AU - Meyer, T. AU - Robles-Carrillo, L. AU - Robson, T. AU - Langer, F. AU - Desai, H. AU - Davila, M. PY - 2009 DA - 2009// TI - Bevacizumab immune complexes activate platelets and induce thrombosis in FCGR2A transgenic mice JO - J Thromb Haemost VL - 7 UR - https://doi.org/10.1111/j.1538-7836.2008.03212.x DO - 10.1111/j.1538-7836.2008.03212.x ID - Meyer2009 ER - TY - JOUR AU - Ferrant, J. L. AU - Benjamin, C. D. AU - Cutler, A. H. AU - Kalled, S. L. AU - Hsu, Y. -. M. AU - Garber, E. A. PY - 2004 DA - 2004// TI - The contribution of Fc effector mechanisms in the efficacy of anti-CD154 immunotherapy depends on the nature of the immune challenge JO - Int Immunol VL - 16 UR - https://doi.org/10.1093/intimm/dxh162 DO - 10.1093/intimm/dxh162 ID - Ferrant2004 ER - TY - JOUR AU - Quezada, S. A. AU - Eckert, M. AU - Adeyi, O. A. AU - Schned, A. R. AU - Noelle, R. J. AU - Burns, C. M. PY - 2003 DA - 2003// TI - Distinct mechanisms of action of anti-CD154 in early versus late treatment of murine lupus nephritis JO - Arthritis Rheum VL - 48 UR - https://doi.org/10.1002/art.11230 DO - 10.1002/art.11230 ID - Quezada2003 ER - TY - JOUR AU - Nagelkerken, L. AU - Haspels, I. AU - Rijs, W. AU - Blauw, B. AU - Ferrant, J. L. AU - Hess, D. M. PY - 2004 DA - 2004// TI - FcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodies JO - J Immunol VL - 173 UR - https://doi.org/10.4049/jimmunol.173.2.993 DO - 10.4049/jimmunol.173.2.993 ID - Nagelkerken2004 ER - TY - JOUR AU - Pau, E. AU - Chang, N. H. AU - Loh, C. AU - Lajoie, G. AU - Wither, J. E. PY - 2011 DA - 2011// TI - Abrogation of pathogenic IgG autoantibody production in CD40L gene-deleted lupus-prone New Zealand Black mice JO - Clin Immunol VL - 139 UR - https://doi.org/10.1016/j.clim.2011.02.005 DO - 10.1016/j.clim.2011.02.005 ID - Pau2011 ER - TY - JOUR AU - Anderson, C. L. AU - Chacko, G. W. AU - Osborne, J. M. AU - Brandt, J. T. PY - 1995 DA - 1995// TI - The Fc receptor for immunoglobulin G (Fc gamma RII) on human platelets JO - Semin Thromb Hemost VL - 21 UR - https://doi.org/10.1055/s-2007-1000374 DO - 10.1055/s-2007-1000374 ID - Anderson1995 ER - TY - JOUR AU - Xie, J. H. AU - Yamniuk, A. P. AU - Borowski, V. AU - Kuhn, R. AU - Susulic, V. AU - Rex-Rabe, S. PY - 2014 DA - 2014// TI - Engineering of a novel anti-CD40L domain antibody for treatment of autoimmune diseases JO - J Immunol VL - 192 UR - https://doi.org/10.4049/jimmunol.1303239 DO - 10.4049/jimmunol.1303239 ID - Xie2014 ER - TY - JOUR AU - Lilbert, J. AU - Burnett, R. PY - 2003 DA - 2003// TI - Main vascular changes seen in the saline controls of continuous infusion studies in the Cynomolgus monkey over an eight-year period JO - Toxicol Pathol VL - 31 UR - https://doi.org/10.1080/01926230390204306 DO - 10.1080/01926230390204306 ID - Lilbert2003 ER - TY - JOUR AU - Gavins, F. N. AU - Li, G. AU - Russell, J. AU - Perretti, M. AU - Granger, D. N. PY - 2011 DA - 2011// TI - Microvascular thrombosis and CD40/CD40L signaling JO - J Thromb Haemost VL - 9 UR - https://doi.org/10.1111/j.1538-7836.2010.04176.x DO - 10.1111/j.1538-7836.2010.04176.x ID - Gavins2011 ER - TY - JOUR AU - Crow, A. R. AU - Leytin, V. AU - Starkey, A. F. AU - Rand, M. L. AU - Lazarus, A. H. PY - 2003 DA - 2003// TI - CD154 (CD40 ligand)-deficient mice exhibit prolonged bleeding time and decreased shear-induced platelet aggregates JO - J Thromb Haemost VL - 1 UR - https://doi.org/10.1046/j.1538-7836.2003.t01-1-00115.x DO - 10.1046/j.1538-7836.2003.t01-1-00115.x ID - Crow2003 ER - TY - JOUR AU - Novo, S. AU - Basili, S. AU - Tantillo, R. AU - Falco, A. AU - Davì, V. AU - Novo, G. PY - 2005 DA - 2005// TI - Soluble CD40L and cardiovascular risk in asymptomatic low-grade carotid stenosis JO - Stroke VL - 36 UR - https://doi.org/10.1161/01.STR.0000154878.58398.14 DO - 10.1161/01.STR.0000154878.58398.14 ID - Novo2005 ER -